Literature DB >> 10848375

Drug treatments for schizophrenia.

C Adams1, P Wilson, S Gilbody, A M Bagnall, R Lewis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10848375      PMCID: PMC1743493          DOI: 10.1136/qhc.9.1.73

Source DB:  PubMed          Journal:  Qual Health Care        ISSN: 0963-8172


× No keyword cloud information.
  28 in total

1.  A two-year clinical and economic follow-up of patients on clozapine.

Authors:  G Honigfeld; J Patin
Journal:  Hosp Community Psychiatry       Date:  1990-08

2.  Myocarditis and cardiomyopathy associated with clozapine.

Authors:  J G Kilian; K Kerr; C Lawrence; D S Celermajer
Journal:  Lancet       Date:  1999-11-27       Impact factor: 79.321

3.  National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome.

Authors:  A Breier; J L Schreiber; J Dyer; D Pickar
Journal:  Arch Gen Psychiatry       Date:  1991-03

4.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

5.  Cost analysis of the treatment of schizophrenia in the UK: a comparison of olanzapine and haloperidol.

Authors:  S Almond; O O'Donnell
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

6.  Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.

Authors:  H Y Meltzer; P Cola; L Way; P A Thompson; B Bastani; M A Davies; B Snitz
Journal:  Am J Psychiatry       Date:  1993-11       Impact factor: 18.112

Review 7.  Schizophrenia--a high-risk factor for suicide: clues to risk reduction.

Authors:  C B Caldwell; I I Gottesman
Journal:  Suicide Life Threat Behav       Date:  1992

8.  Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom.

Authors:  L M Davies; M F Drummond
Journal:  Br J Psychiatry       Date:  1993-01       Impact factor: 9.319

9.  Premature deaths in schizophrenia and affective disorders. An analysis of survival curves and variables affecting the shortened survival.

Authors:  M T Tsuang; R F Woolson; J A Fleming
Journal:  Arch Gen Psychiatry       Date:  1980-09

10.  Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.

Authors:  J M Alvir; J A Lieberman; A Z Safferman; J L Schwimmer; J A Schaaf
Journal:  N Engl J Med       Date:  1993-07-15       Impact factor: 91.245

View more
  2 in total

Review 1.  Amisulpride: a review of its use in the management of schizophrenia.

Authors:  M P Curran; C M Perry
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Quetiapine. A review of its use in the management of schizophrenia.

Authors:  Susan M Cheer; Antona J Wagstaff
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.